Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May;12(5):269-80.
doi: 10.1038/nrneurol.2016.46. Epub 2016 Apr 11.

Neuropsychiatric sequelae of stroke

Affiliations
Review

Neuropsychiatric sequelae of stroke

José M Ferro et al. Nat Rev Neurol. 2016 May.

Abstract

Stroke survivors are often affected by psychological distress and neuropsychiatric disturbances. About one-third of stroke survivors experience depression, anxiety or apathy, which are the most common neuropsychiatric sequelae of stroke. Neuropsychiatric sequelae are disabling, and can have a negative influence on recovery, reduce quality of life and lead to exhaustion of the caregiver. Despite the availability of screening instruments and effective treatments, neuropsychiatric disturbances attributed to stroke are currently underdiagnosed and undertreated. Stroke severity, stroke-related disabilities, cerebral small vessel disease, previous psychiatric disease, poor coping strategies and unfavourable psychosocial environment influence the presence and severity of the psychiatric sequelae of stroke. Although consistent associations between psychiatric disturbances and specific stroke locations have yet to be confirmed, functional MRI studies are beginning to unveil the anatomical networks that are disrupted in stroke-associated psychiatric disorders. Evidence regarding biochemical and genetic biomarkers for stroke-associated psychiatric disorders is still limited, and better understanding of the biological determinants and pathophysiology of these disorders is needed. Investigation into the management of these conditions must be continued, and should include pilot studies to assess the benefits of innovative behavioural interventions and large-scale cooperative randomized controlled pharmacological trials of drugs that are safe to use in patients with stroke.

PubMed Disclaimer

References

    1. J Affect Disord. 2013 Jan 10;144(1-2):179-82 - PubMed
    1. Stroke. 2009 Feb;40(2):523-9 - PubMed
    1. Stroke. 2006 Jan;37(1):156-61 - PubMed
    1. Stroke. 2012 Aug;43(8):2192-7 - PubMed
    1. Neurology. 2006 Feb 28;66(4):513-6 - PubMed

MeSH terms